Does EMICIZUMAB-KXWH Cause Gait inability? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Gait inability have been filed in association with EMICIZUMAB-KXWH. This represents 0.1% of all adverse event reports for EMICIZUMAB-KXWH.
7
Reports of Gait inability with EMICIZUMAB-KXWH
0.1%
of all EMICIZUMAB-KXWH reports
0
Deaths
1
Hospitalizations
How Dangerous Is Gait inability From EMICIZUMAB-KXWH?
Of the 7 reports, 1 (14.3%) required hospitalization.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMICIZUMAB-KXWH. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does EMICIZUMAB-KXWH Cause?
Haemorrhage (3,612)
No adverse event (654)
Off label use (542)
Haemarthrosis (487)
Fall (484)
Arthralgia (385)
Contusion (321)
Epistaxis (313)
Pain (260)
Head injury (248)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which EMICIZUMAB-KXWH Alternatives Have Lower Gait inability Risk?
EMICIZUMAB-KXWH vs EMPAGLIFLOZIN
EMICIZUMAB-KXWH vs EMPAGLIFLOZIN\LINAGLIPTIN
EMICIZUMAB-KXWH vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN
EMICIZUMAB-KXWH vs EMPAGLIFLOZIN\METFORMIN
EMICIZUMAB-KXWH vs EMSAM